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ABSTRACT
Objective: To develop a psychotherapy
rating scale to measure therapist adher-
ence in the Strong Without Anorexia
Nervosa (SWAN) study, a multi-center
randomized controlled trial comparing
three different psychological treatments
for adults with anorexia nervosa. The
three treatments under investigation
were Enhanced Cognitive Behavioural
Therapy (CBT-E), the Maudsley Anorexia
Nervosa Treatment for Adults (MAN-
TRA), and Specialist Supportive Clinical
Management (SSCM).
Method: The SWAN Psychotherapy Rat-
ing Scale (SWAN-PRS) was developed, after
consultation with the developers of the
treatments, and refined. Using the SWAN-
PRS, two independent raters initially
rated 48 audiotapes of treatment sessions
to yield inter-rater reliability data. One
rater proceeded to rate a total of 98
audiotapes from 64 trial participants.
Results: The SWAN-PRS demonstrated
sound psychometric properties, and
was considered a reliable measure of
therapist adherence. The three treat-
ments were highly distinguishable by
independent raters, with therapists
demonstrating significantly more
behaviors consistent with the actual
allocated treatment compared to the
other two treatment modalities. There
were no significant site differences in
therapist adherence observed.
Discussion: The findings provide sup-
port for the internal validity of the SWAN
study. The SWAN-PRS was deemed suita-
ble for use in other trials involving CBT-E,
MANTRA, or SSCM. VC 2015 The Authors.
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Introduction
In clinical trials, measuring the extent to which
therapists implement treatments in accordance
with their respective protocols is essential, in order
for conclusions regarding treatment efficacy to be
confidently determined.1,2 Assessing therapist
adherence also provides an indication whether
treatments under investigation can be differenti-
ated.2,3 Therapist adherence is commonly meas-
ured by reviewing recordings of therapy sessions,
and rating whether core treatment components are
observed using a suitable rating scale. These rating
scales also tend to include items that measure non-
specific factors, such as therapist empathy.1,4,5 A
well-known adherence scale is the Collaborative
Study Psychotherapy Rating Scale (CSPRS), which
was designed to assess whether therapists involved
in the National Institute of Mental Health Treat-
ment of Depression Collaborative Research Pro-
gram adhered to the four treatments being
compared (Unpublished manuscript).6,7
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Because there are no “gold standard” treatments
for adults with anorexia nervosa (AN), it is particu-
larly important to ensure treatments involved in
randomized clinical trials (RCT) are implemented
in line with their specifications. Only one study has
examined therapist adherence in a RCT of treat-
ments for AN.8,9 McIntosh et al.9 used a modified
version of the CSPRS (CSPRS-AN) to investigate
adherence to, and differentiation between Cogni-
tive Behavioural Therapy, Interpersonal Psycho-
therapy and Specialist Supportive Clinical
management (SSCM). Results indicated that the
90-item CSPRS-AN was able to differentiate treat-
ments reliably, and no differences in therapist
adherence were found.
The current study examined therapist adherence
in the Strong Without Anorexia Nervosa (SWAN)
study, a multi-center RCT comparing three differ-
ent psychological treatments for adults with AN10:
Enhanced Cognitive Behavioural Therapy (CBT-
E)11; Maudsley Model of Anorexia Nervosa Treat-
ment for Adults (MANTRA)12,13; and SSCM.14 The
aims were to (1) develop and test a measure of
therapist adherence for use in the SWAN study, (2)
assess therapist adherence to the treatments under
investigation, and (3) examine inter-site differences
in therapist adherence.
Method
Participants
Participants in the SWAN study were 120 individuals
(97.5% female) recruited at three Australian sites: Perth
(n5 80); Adelaide (n5 21), and Sydney (n5 19). Partici-
pants in the current study were 64 females drawn from
this broader participant pool (Age: M5 26.72,
SD5 10.21). Ethics approval was obtained and all partici-
pants provided informed consent.
Inclusion criteria for the SWAN study were: body
mass index (BMI) 14.0 and 18.5; aged 17 years and
over; and meeting diagnostic criteria A and B for AN in
DSM-IV-TR.15 Exclusion criteria were severe medical or
suicidal risk, inability to complete full treatment course,
and current use of olanzapine or other active psycho-
therapy. Participants were randomized to one of the
three treatments. Number of treatment sessions allo-
cated was titrated according to BMI (40 sessions for
BMI: <16; 30 sessions for BMI: 16–17.5; 25 sessions for
BMI: 17.5–18.5).
Therapists were psychologists (n 5 8) with at least two
years of experience in delivering specialized psychologi-
cal treatments for eating disorders. Therapists delivered
all three treatments and received training by the treat-
ment developers prior to study commencement. Thera-
pists attended 2 h of supervision weekly with chief
investigators (SB, TW, PH).
Raters were two female postgraduate clinical psychol-
ogy students (ET, LA). Raters received 15 h of training in
the use of the SWAN Psychotherapy Rating Scale to
ensure consistent interpretation of scale items.
Measures
Audiotapes. Ninety-eight audiotapes of full therapy
sessions were randomly selected by the trial co-ordinator
(KA; Perth5 72 audiotapes, Adelaide5 9; Sydney5 17).
Audiotapes were selected from the early–mid treatment
phase and the mid–late treatment phase. One audiotape
was excluded due to crisis management circumstances.
Audiotapes were selected to ensure that all treatments
were comparably represented (CBT-E5 30 audiotapes;
MANTRA5 32; SSCM5 35).
SWAN Psychotherapy Rating Scales (SWAN-PRS). The
SWAN-PRS was developed by adapting the CSPRS-AN9 to
form a 52-item measure with 15 CBT-E specific items; 10
MANTRA specific items; 4 SSCM specific items; 11 over-
lap items; and 12 Non-Specific items. Items are rated on
a Likert-type scale ranging from 1 (not at all) to 7 (exten-
sively). Higher scores indicate greater adherence to the
specified therapist behavior.
Procedure
Both raters co-rated 48 audiotapes to provide a mea-
sure of inter-rater reliability before Rater 1 proceeded to
rate the remaining 50 audiotapes independently. Raters
were blind to treatment type.
Results
Factor Analysis
Principal Axis Factor Analysis with oblique rota-
tion was used to examine the underlying factor
structure of the SWAN-PRS to allow robust,
treatment-specific subscales to be determined.
The analysis yielded a final SWAN-PRS that
included 8 CBT-E items, 9 MANTRA items, 4
SSCM items, and 12 Non-Specific Factor items.
See Appendices A and B for further details
pertaining to factor analyses and inter-rater
reliability.
Agreement Between Treatment Allocation and
Treatment Classification
Mean subscale scores for CBT-E, MANTRA, and
SSCM were calculated for all audiotapes. The high-
est subscale score for each audiotape was used to
determine treatment classification (e.g., audiotapes
were classified as SSCM, if the SSCM subscale score
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was greater than the MANTRA or CBT-E subscale
scores). Eighty-six percent (N5 83/97) of total
audiotapes were correctly classified as the treat-
ment delivered. For CBT-E (n 5 30), 90.0% tapes
were classified accurately, while 6.7% were misclas-
sified as MANTRA, and 3.3% as SSCM. For MAN-
TRA (n 5 32), 81.2% were correctly classified, while
6.3% were misclassified as CBT-E and 12.5% as
SSCM. For SSCM (n 5 35), 85.7% were accurately
classified, while 8.6% were misclassified as MAN-
TRA and 5.7% as CBT-E. There were no significant
differences between treatments with regards to
agreement between treatment allocation and treat-
ment classification, v2 (df5 2)5 0.961, p5 .619.
One-way ANOVA was used to compare subscale
scores for each treatment category. There was a signif-
icant overall difference found between allocated treat-
ment groups on the CBT-E (F(2)5 97.68, p< .001),
MANTRA (F(2)5 41.50, p5 .001), SSCM (F(2)5 57.68,
p< .001), and Non-specific (F(2)5 7.58, p< .05) sub-
scales. Post hoc analyses (Games-Howell tests) indi-
cated that (i) the CBT-E subscale score was
significantly higher for CBT-E than for MANTRA or
SSCM (p’s< .001), with no significant difference
between MANTRA and SSCM (p5 .754); (ii) the
MANTRA subscale score was significantly higher for
MANTRA than for CBT-E and SSCM (p’s< .001), with
no significant difference between CBT-E and SSCM
(5 .99); (iii) the SSCM subscale score was signifi-
cantly higher for SSCM than for CBT-E and MANTRA
(p’s< .001) and the MANTRA score was significantly
higher than the CBT-E score (p< .05); (iv) the Non-
Specifics subscale score was significantly higher for
CBT-E (M5 5.14, SD5 0.44) than for SSCM (p< .01)
and MANTRA (p< .05) but there was no significant
difference between MANTRA and SSCM (p5 .76).
These results are illustrated in Figure 1.
Site Differences
Fisher’s Exact tests indicated that there were no
significant differences in overall adherence between
sites (p5 .52), nor for CBT-E (p5 .99), MANTRA
(p5 .36) or SSCM, (p5 .61), when considered sepa-
rately. Kruskal–Wallis one-way ANOVA was used to
compare subscale scores for each treatment accord-
ing to site. There were no significant differences
between sites in: CBT-E subscale scores for CBT-E
therapy sessions, F(2)5 0.37, p 5 .691; MANTRA
subscale scores for MANTRA sessions, F(2)5 0.36, p
5 .70; or SSCM subscale scores for SSCM sessions
F(2)5 0.37, p 5 .69. Subscale scores were appropri-
ately higher for the allocated treatment compared to
the other treatments. There were also no significant
differences between sites in Non-Specifics subscale
scores F(2)5 0.26, p5 .08.
Discussion
The CSPRS-AN9 was successfully adapted to form a
therapist adherence measure that can reliably dis-
tinguish between, and measure therapist adher-
ence to, CBT-E, MANTRA, and SSCM. Using the
SWAN-PRS, we were able to demonstrate very high
agreement between actual treatment allocation
and treatment classification in the SWAN study,
with 85.6% of audiotapes being correctly classified
by independent raters. Further, SWAN-PRS ratings
demonstrated significantly higher mean therapy-
specific subscale scores appropriate to the actual
allocated treatment modality. We were also able to
demonstrate that there were no inter-site differen-
ces in therapist adherence with regards to either
treatment classification or mean subscale ratings
for CBT-E, MANTRA, SSCM or the Non-Specifics
subscale. These findings confirm that therapists
adhered strongly to treatment protocols; that the
three treatment modalities could be reliably distin-
guished; and that therapist adherence was not
influenced by treatment site. This not only provides
evidence regarding the relative ease with which
treatments can be disseminated across sites, but
also provides evidence for the internal validity of
the study.
Limitations of the present study included the use
of only two raters to establish inter-rater reliability,
the use of data generated by only one rater for the
remaining analyses, and the uneven distribution of
FIGURE 1. Mean treatment-specific and non-specific subscale
scores for each allocated treatment modality. Error bars represent the
standard error of the mean. Note: CBT-E5 Enhanced Cognitive Behav-
ioural Therapy; MANTRA5Maudsley Anorexia Nervosa Treatment for
Adults; SSCM5 Specialist Supportive Clinical Management.
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audiotapes available for each treatment site. In
addition, whilst the SWAN-PRS was developed to
measure the extent to which therapists demon-
strated behaviors consistent with treatment proto-
cols, it did not measure therapist competence, or
the extent to which therapists delivered treatments
according to an acceptable standard.3,11 Therapist
competence is another important aspect of treat-
ment integrity in outcome research and should
form the focus of future research.
In summary, measuring therapist adherence in
the SWAN study was essential to provide evidence
of the scientific quality of the trial. The rigorous
development and piloting process involved in the
development of the SWAN-PRS resulted in a reli-
able measure of therapist adherence to the three
treatment modalities under investigation. The
SWAN-PRS can now be used to demonstrate thera-
pist adherence in other contexts involving these
treatments. It could also generate useful informa-
tion to assist with therapist training.
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Appendix A: Interrater Reliability
Intra-class coefficients16 were used to assess
inter-rater reliability for CBT-E, MANTRA, SSCM,
and Non-Specific subscale ratings. Cohen’s Kappa
was used to assess inter-rater reliability for treat-
ment classification, with the strength of the Kappa
statistic defined according to the following criteria:
Poor (<0.20), fair (0.21–0.40), moderate (0.41–0.60),
substantial (0.61–0.80), and very high agreement
(0.81–1.00).17,18
Intraclass coefficients yielded a high level of
agreement between raters according to Cohen’s
Kappa for the CBT-E (0.83), MANTRA (0.84), SSCM
(0.79), and Non-Specific (0.68) subscales. Very high
agreement between raters (Kappa5 0.81, p< .001)
was established for classification of treatments
using the SWAN-PRS. Overall, 87.5% (n5 42/48) of
audiotapes were classified as the same treatment
by both raters with high inter-rater reliability dem-
onstrated for CBT (91.67%), MANTRA (88.23%),
and SSCM (84.21%), when considered separately.
Appendix B: Factor Analysis of the SWAN-PRS
An exploratory factor analysis was used to
ascertain the underlying factor structure of the
SWAN-PRS. Overlap items and Non-Specific
items were excluded from the exploratory factor
analysis, in order to obtain a factor structure
reflective of the “pure” treatment components.
Three factors were initially requested, as the
items were specifically designed to measure three
treatment-specific subscales. However, given the
position of SSCM as an atheoretical treatment
with broad underpinnings found in clinical man-
agement and supportive psychotherapy, it was
expected that the SSCM items may load across all
factors.14
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The item inter-correlation matrix was examined
and items that correlated weakly (<0.40) with other
items on the same subscale were removed. The
remaining items were entered into a Principal Axis
Factor analysis with oblique rotation, with three fac-
tors requested. The three factors explained 60.1% of
the variance, although the third factor was weak
(Eigenvalues 6.98, 4.94, and 1.23). The first two fac-
tors were clearly representative of the CBT-E and
MANTRA subscales. As expected, the four SSCM
TABLE B1. Factor loadings for the rotated factors: SWAN-PRS treatment-specific subscales
Item Subscale
Factor Loading
Communality1 2
Did the therapist make use of a collaborative, active, empathic stance, to
encourage the client to make changes?
MANTRA 0.90 0.08 0.74
Did the therapist and client: (i) collaboratively develop a formulation OR
refer to such a formulation as previously developed with the client, mak-
ing reference to thinking styles, social and emotional functioning, inter-
personal factors, and the valued nature of Anorexia OR (ii) explore
maintaining mechanisms (e.g., pro-anorexic beliefs, social/emotional func-
tioning, cognitive rigidity, responses of close others, perfectionism) reflect-
ing a shared understanding of specific targets for treatment of specific
targets for treatment?
0.85 20.04 0.76
Was the therapist motivational, reflective, client-focused and empathic
(e.g., affirm, emphasize control, support, ask open questions, reflect the cli-
ent’s comments, ask permission before giving advice, explore the client’s
viewpoint)?
0.84 20.11 0.81
Did the therapist explore the client’s values and valued domains, and how
these have been affected by anorexia, OR refer back to values work as
previously introduced?
0.72 20.03 0.54
Did the therapist encourage the client to externalize their eating disorder
(e.g., through discussions of anorexia as something outside of and separate
to themselves), OR show evidence of externalization through discussions
of “the anorexia (or eating disorder, etc)” or “the anorexic voice”?
.72 .06 .59
When questions were used by the therapist, to what extent were they open-
ended?
0.66 0.12 0.55
To what extent did the therapist make use of reflections (simple, double-
sided, complex), and use more reflections than questions?
0.62 20.16 0.54
Did the therapist refer to previously introduced writing tasks (e.g., assigned
at-home tasks) or therapeutic letters, OR set writing tasks for between-
session work?
0.60 20.07 0.51
Did the therapist provide feedback on neuropsychological test results and
explore with the client how these may relate to eating disorder symp-
toms, OR discuss links between the client’s thinking style and their eat-
ing, behavior or emotions?
0.51 20.06 0.61
Did the therapist ask the client to report specific thoughts or beliefs (e.g.,
dietary rules, thoughts regarding weight or shape) that the client experi-
enced either in the session or in a situation that occurred prior to the
session?
CBT-E 20.01 0.85 0.71
Did the therapist collaboratively develop a formulation with the client,
making reference to the over-evaluation of eating, weight and shape, strict
dietary restraint, mood intolerance, and self-maintaining feedback loops,
which allowed for a shared understanding of the factors maintaining the
eating disorder and specific targets for treatment, OR explicitly refer to
such a formulation as previously developed?
20.06 0.83 0.74
Did the therapist encourage the client to record food intake, behaviors and
feelings between sessions, OR review the client’s records of food intake,
behaviors and feelings from the previous week?
20.12 0.81 0.72
To what extent did the therapist use Socratic questioning to promote
guided discovery (e.g “what does that tell you about. . .”)?
0.16 0.75 0.58
Did the therapist encourage the client to either (i) view their thoughts as
beliefs which may or may not be true, rather than as established facts
(e.g., “feeling fat), OR (ii) use currently available evidence or information
(including the client’s prior experiences) to test the validity of the client’s
thoughts/beliefs, OR (iii) consider alternative perspectives or viewpoints
for events, besides the client’s initial explanations for those events?
0.08 0.70 0.54
Relationship of mood, events and eating: Did the therapist encourage the
client to draw links between mood/events and eating, either in relation
to past experiences or when discussing future possible experiences?
0.06 0.64 0.41
Did the therapist work with the client to schedule or structure eating behav-
ior/compensatory behavior/exercise?
20.09 0.56 0.47
Did the therapist work collaboratively with the client to formulate and fol-
low a specific agenda for the session?
0.11 0.55 0.51
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items tended to cross-load across the first two fac-
tors rather than loading strongly on a third factor.
Examination of the item inter-correlation matrix
showed that while the four SSCM items were all
highly and positively correlated (average
correlation5 .56), they were negatively and weakly
correlated with the CBT-E and MANTRA items
(all< 36). Therefore it was decided to remove the
SSCM items and re-run the factor analysis with a
two factor solution requested. Fifty-six percent of
the variance was explained, with 8 items loading
strongly (>.5) onto the CBT-E factor (eigenvalue
3.28), and nine items loading (>.5) onto the MAN-
TRA factor (eigenvalue 3.28). Table B1 displays the
items, factor loadings, and communalities for the
rotated factors. A reliability analysis was used to
assess internal consistency, and results revealed an
acceptable Cronbach’s alpha for the CBT-E (a5 0.89)
and MANTRA (a5 0.91) factors. An acceptable Cron-
bach’s alpha18 was also found for the four-item
SSCM subscale (a5 0.76). The SSCM and Non-
Specific factor subscale items are listed in Table B2.
TABLE B2. SWAN-PRS SSCM and non-specific factors items
Item Subscale
To what extent did the therapist follow the client’s lead in generating issues for discussion? SSCM
To what extent did the therapist collaboratively generate a list of target symptoms with the client, OR refer back
to the target symptom checklist and review functioning in relation to this list?
To what extent did the therapist give specific advice or suggestions regarding eating or other issues?
To what extent did the therapist deal with a problem without use of specific Cognitive Behavioural/Cognitive-
Interpersonal/Motivational Interviewing techniques?
Was the therapist empathetic towards the client (i.e., did they convey an intimate understanding of and sensitivity
to the client’s experiences and feelings?
Non-specific
Factors
Level of Verbal Activity: How much did the therapist talk?
How much did the therapist direct or guide the session in a subtle way?
How much rapport was there between the therapist and client (i.e., how well did the therapist and client
get along?
Did the therapist convey warmth?
How involved (e.g., demonstrating interest, encouraging etc.) was the therapist?
Did the therapist appear to allow silence to continue (or use minimal encouragement such as “uh huh,” “mm-
hmm,” “okay”) as a means of encouraging the client to talk?
Was the therapist supportive of the client by acknowledging the client’s gains during therapy OR by reassuring the
client that gains will be forthcoming?
Did the therapist actively attempt to engage the client in working together to explore therapeutic issues?
Summarizing: Did the therapist summarize OR encourage the client to summarize session content of a previous
or the current session?
Did the therapist convey that she understood the client’s problems and is able to help the client?
How much did the therapist direct or guide the session in an explicit way?
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